[New etiopathogenetic and therapeutic studies in threatened abortion].
D000033:Abortion, Threatened / Q000209:etiology / Q000276:immunology / Q000628:therapy; D000328:Adult; D000614:Aminocaproates / Q000627:therapeutic use*; D007611:Aprotinin / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000150:complications; D004967:Estrogens / Q000378:metabolism; D005260:Female; D005341:Fibrinolysin / Q000096:biosynthesis; D006801:Humans; D010447:Peptide Hydrolases / Q000096:biosynthesis; D011247:Pregnancy; D011372:Progestins / Q000378:metabolism
D000614:Aminocaproates; D004967:Estrogens; D011372:Progestins; D007611:Aprotinin; D010447:Peptide Hydrolases; D005341:Fibrinolysin
Nuovi indirizzi exiopatogenetici e terapeutici in tema di minacce d'aborto.